Daesung Microbiological Labs Co Ltd
036480
Company Profile
Business description
Daesung Microbiological Labs Co Ltd is a veterinary pharmaceutical company that has contributed to the development of Korea's livestock industry by producing only high-quality veterinary pharmaceuticals. Its products include preventive vaccines, antibiotics, antibacterials, anthelmintics, nutritional supplements, antipyretics, analgesics, anti-inflammatory drugs, probiotic enzymes, immune boosters, and disinfectants.
Contact
103 Deokyeong-daero
Gyeonggi-do
Uiwang-si
KORT: +82 25531104
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2026
Employees
135
Stocks News & Analysis
stocks
Australia’s oldest REIT undervalued
This REIT remains undervalued as trophy properties shine through.
stocks
Stop asking if there’s a stock market bubble. Ask this instead.
Why earnings growth might be more important when assessing frothy market conditions.
stocks
Are negative AI narratives holding this ASX share back?
This company is unlikely to be disrupted by AI
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,929.10 | 73.90 | -0.82% |
| CAC 40 | 8,403.99 | 36.66 | 0.44% |
| DAX 40 | 24,995.81 | 368.92 | 1.50% |
| Dow JONES (US) | 52,319.20 | 136.46 | 0.26% |
| FTSE 100 | 10,497.12 | 12.90 | 0.12% |
| HKSE | 22,881.02 | 145.66 | -0.63% |
| NASDAQ | 26,213.72 | 393.58 | 1.52% |
| Nikkei 225 | 70,453.91 | 391.59 | 0.56% |
| NZX 50 Index | 13,604.74 | 16.92 | -0.12% |
| S&P 500 | 7,499.36 | 58.93 | 0.79% |
| S&P/ASX 200 | 8,717.60 | 77.00 | -0.88% |
| SSE Composite Index | 4,094.40 | 20.50 | 0.50% |